Spondin-2 is a novel diagnostic biomarker for laryngeal squamous cell carcinoma
In conclusion, spondin-2 might be a novel therapeutic target and prognostic biomarker for LSCC patients.
Source: Pathology Research and Practice - Category: Pathology Source Type: research
More News: Cancer & Oncology | Carcinoma | Genetics | Laryngeal Cancer | Pathology | Skin Cancer | Squamous Cell Carcinoma | Study